相关实验视频
Updated: Jul 16, 2025

04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
82
终止第二个三个月的怀孕与胎盘增殖谱系障碍
Qi Li1, Weishe Zhang2,3, Caihong Hu2
1Reproductive Medicine Center, Xiangya Hospital Central South University, Changsha, China.
The Libyan journal of medicine
|September 18, 2023
概括
对于胎盘增殖谱系障碍 (PASD) 的第二个三个月终止怀孕,阴道和剖腹产方法的成功率相似. 手术前的动脉栓塞并没有显著改善PASD剖腹产终止的结果.
科学领域:
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 干预性放射学 干预性放射学
- 手术产科医生手术产科医生
背景情况:
- 胎盘突发性谱系障碍 (PASD) 对第二个三个月的妊娠终止提出了复杂的挑战.
- 干预性放射技术的有效性,如动脉栓塞,在妊娠终止期间管理PASD并未得到充分确立.
研究的目的:
- 评估在第二个三个月期间患有PASD的患者中终止怀孕的结果.
- 在这些情况下,评估术前干预放射技术的有效性.
主要方法:
- 追溯分析48名PASD患者在第二个三个月中进行妊娠终止.
- 通过阴道终止和剖腹产之间的结果比较.
- 评估手术前动脉栓塞的影响.
主要成果:
- 通过阴道 (80.00%) 和剖腹产 (92.86%) 终止之间的成功率没有显著差异.
- 与非栓塞组相比,动脉栓塞在成功率或血液损失方面没有显著差异.
- 在阴道终止时,栓塞与更早的妊娠周和更少的血液损失有关.
结论:
- 需要进一步的研究来澄清阴道终止在第二季度PASD的疗效.
- 动脉栓塞在PASD患者的剖腹产终止过程中没有显示出增强的有效性.
更多相关视频
09:52Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
26.9K
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
19.7K
相关概念视频
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Mitral Valve Prolapse III: Nursing Management
16
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
16